Predictive biomarkers of renal allograft failure

Bibliography

• Aalten J, Christiaans MH, De Fijter H, et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int 2006;19:901-7
   PubMed Web of Science ®Google Scholar
• Jushinskis J, Bicans J, Suhorukov V, et al. Vascular access outcomes as a predictor of development of chronic allograft nephropathy. Transplant Proc 2006;38:2657-8
   PubMed Web of Science ®Google Scholar
• Lisik W, Gontarczyk G, Kosieradzki M, et al. Intraoperative blood flow measurements in organ allografts can predict postoperative function. Transplant Proc 2007;39:371-2
   PubMed Web of Science ®Google Scholar
• Vallejos A, Alperovich G, Moreso F, et al. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome. Nephrol Dial Transplant 2005;20:2511-6
   PubMed Web of Science ®Google Scholar
• Einollahi B, Bakhtiari P, Simforoosh N, et al. Renal allograft accumulation of technetium-99m sulfur colloid as a predictor of graft rejection. Transplant Proc 2005;37:2973-5
   PubMed Web of Science ®Google Scholar
• Yehia M, Matheson PJ, Merrilees MJ, et al. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology (Carlton) 2006;11:261-6
   PubMed Web of Science ®Google Scholar
• Palomar R, Ruiz JC, Mayorga M, et al. The macrophage infiltration index and matrix metalloproteinase-II expression as a predictor of chronic allograft rejection. Transplant Proc 2004;36:2662-3
   PubMed Web of Science ®Google Scholar
• Suresh V, Carey BS, Shaw S, et al. A retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogeneic renal transplantation. Transpl Int 2005;18:1067-71
   PubMed Web of Science ®Google Scholar
• Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999;163:2267-75
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006;81:643-54
   PubMed Web of Science ®Google Scholar
• Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002;62:311-8
   PubMed Web of Science ®Google Scholar
• McEwan P, Baboolal K, Dixon S, et al. Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years. Curr Med Res Opin 2005;21:1793-800
   PubMed Web of Science ®Google Scholar
• Marques GG, Goenaga PE, Royo FJ, et al. Evolution of the renal function is a better predictor of long-term survival than serum creatinine. Transplant Proc 2005;37:3701-4
   PubMed Web of Science ®Google Scholar
• Salvadori M, Rosati A, Bock A, et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006;81:202-6
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-56
   PubMed Web of Science ®Google Scholar
• Donadelli R, Zanchi C, Morigi M, et al. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J Am Soc Nephrol 2003;14:2436-46
   PubMed Web of Science ®Google Scholar
• First MR, Vaidya PN, Maryniak RK, et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 1984;38:607-12
   PubMed Web of Science ®Google Scholar
• Peddi VR, Dean DE, Hariharan S, et al. Proteinuria following renal transplantation: correlation with histopathology and outcome. Transplant Proc 1997;29:101-3
   PubMed Web of Science ®Google Scholar
• Yildiz A, Erkoc R, Sever MS, et al. The prognostic importance of severity and type of post-transplant proteinuria. Clin Transplant 1999;13:241-4
   PubMed Web of Science ®Google Scholar
• Halimi JM, Buchler M, Al Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007;7:618-25
   PubMed Web of Science ®Google Scholar
• Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients–a prospective cohort study. Am J Transplant 2007;7:818-24
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Lorenz M, Kramar R, et al. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 2004;4:2075-81
   PubMed Web of Science ®Google Scholar
• Weir MR. Is anemia a predictor for mortality and loss of graft function in kidney transplant recipients? Am J Transplant 2007;7:731-2
   PubMed Web of Science ®Google Scholar
• Molina P, Gavela E, Sancho A, et al. Erythropoietin treatment in the sixth posttransplant month as a prognostic factor for renal allograft survival. Transplant Proc 2006;38:2441-4
   PubMed Web of Science ®Google Scholar
• Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 2005;80:1194-7
   PubMed Web of Science ®Google Scholar
• Panigrahi A, Gupta N, Siddiqui JA, et al. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation. Transplant Proc 2007;39:759-60
   PubMed Web of Science ®Google Scholar
• D'Elios MM, Josien R, Manghetti M, et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 1997;51:1876-84
   PubMed Web of Science ®Google Scholar
• Amirzargar A, Lessanpezeshki M, Fathi A, et al. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc 2005;37:2985-7
   PubMed Web of Science ®Google Scholar
• Fitzgerald JT, Johnson JR, Perez RV. Pre-transplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation. Clin Transplant 2004;18:434-9
   PubMed Web of Science ®Google Scholar
• Yamada K, Hatakeyama E, Arita S, et al. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system. Clin Exp Nephrol 2003;7:238-42
   PubMedGoogle Scholar
• Hancock WW, Lu B, Gao W, et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000;192:1515-20
   PubMed Web of Science ®Google Scholar
• Hancock WW, Gao W, Csizmadia V, et al. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001;193:975-80
   PubMed Web of Science ®Google Scholar
• Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001;37:518-31
   PubMed Web of Science ®Google Scholar
• Akalin E, Dikman S, Murphy B, et al. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003;3:1116-20
   PubMed Web of Science ®Google Scholar
• Lazzeri E, Rotondi M, Mazzinghi B, et al. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation 2005;79:1215-20
   PubMed Web of Science ®Google Scholar
• Rotondi M, Rosati A, Buonamano A, et al. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 2004;4:1466-74
   PubMed Web of Science ®Google Scholar
• Matz M, Beyer J, Wunsch D, et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006;69:1683-90
   PubMed Web of Science ®Google Scholar
• Denton MD, Geehan CS, Alexander SI, et al. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation. J Exp Med 1999;190:555-66
   PubMed Web of Science ®Google Scholar
• Savage CO, Brooks CJ. Human vascular endothelial cells do not induce anergy in allogeneic CD4+ T cells unless costimulation is prevented. Transplantation 1995;60:734-40
   PubMed Web of Science ®Google Scholar
• Kapoor A, Morita K, Engeman TM, et al. Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells. Transplantation 2000;69:1147-55
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Koga S, Novick AC, et al. T-cell mediated induction of allogeneic endothelial cell chemokine expression. Transplantation 2003;75:529-36
   PubMed Web of Science ®Google Scholar
• Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 2005;16:1849-58
   PubMed Web of Science ®Google Scholar
• Simmons EM, Langone A, Sezer MT, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005;79:914-9
   PubMed Web of Science ®Google Scholar
• Varagunam M, Finney H, Trevitt R, et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 2004;43:502-7
   PubMed Web of Science ®Google Scholar
• Ozdemir NF, Elsurer R, Ibis A, et al. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival. Transplant Proc 2007;39:934-7
   PubMed Web of Science ®Google Scholar
• Sezer S, Akcay A, Ozdemir FN, et al. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clin Transplant 2004;18:722-5
   PubMed Web of Science ®Google Scholar
• Lauzurica R, Pastor C, Bayes B, et al. Pretransplant pregnancy-associated plasma protein-a as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events. Transplantation 2005;80:1441-6
   PubMed Web of Science ®Google Scholar
• Bayes Genis A, Conover CA, Overgaard MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-9
   PubMed Web of Science ®Google Scholar
• Hall BM. Cells mediating allograft rejection. Transplantation 1991;51:1141-51
   PubMed Web of Science ®Google Scholar
• Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001;344:947-54
   PubMed Web of Science ®Google Scholar
• Susal C, Pelzl S, Simon T, Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 2004;36:29-34
   PubMed Web of Science ®Google Scholar
• Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood interleukin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection. Transplantation 2004;77:1589-95
   PubMed Web of Science ®Google Scholar
• Weimer R, Zipperle S, Daniel V, et al. Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection. Transplantation 1996;62:1606-14
   PubMed Web of Science ®Google Scholar
• Weimer R, Zipperle S, Daniel V, et al. Superior 3-year kidney graft function in patients with impaired pretransplant Th2 responses. Transpl Int 1998;11(Suppl 1):S350-6
   PubMedGoogle Scholar
• Susal C, Pelzl S, Dohler B, Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002;13:1650-6
   PubMedGoogle Scholar
• Heinemann FM, Rebmann V, Witzke O, et al. Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation. Transplantation 2007;83:706-11
   PubMed Web of Science ®Google Scholar
• Vaidya S, Partlow D, Barnes T, Gugliuzza K. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies. Transplantation 2006;82:1606-9
   PubMed Web of Science ®Google Scholar
• Rajakariar R, Jivanji N, Varagunam M, et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 2005;5:1922-5
   PubMed Web of Science ®Google Scholar
• Cinti P, Pretagostini R, Arpino A, et al. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 2005;79:599-601
   PubMed Web of Science ®Google Scholar
• Weimer R, Susal C, Yildiz S, et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 2006;6:1865-74
   PubMed Web of Science ®Google Scholar
• Langan LL, Park LP, Hughes TL, et al. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 2007;7:847-56
   PubMed Web of Science ®Google Scholar
• Rodriguez LM, Paris SC, Arbelaez M, et al. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss. Hum Immunol 2007;68:652-60
   PubMed Web of Science ®Google Scholar
• Seiter S, Weber B, Tilgen W, Zoller M. Down-modulation of host reactivity by anti-CD44 in skin transplantation. Transplantation 1998;66:778-91
   PubMed Web of Science ®Google Scholar
• Knoflach A, Azuma H, Magee C, et al. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. J Am Soc Nephrol 1999;10:1059-66
   PubMed Web of Science ®Google Scholar
• Rouschop KM, Roelofs JJ, Rowshani AT, et al. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. Nephrol Dial Transplant 2005;20:2248-54
   PubMed Web of Science ®Google Scholar
• Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353:2342-51
   PubMed Web of Science ®Google Scholar
• Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639-45
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, rules in liver regeneration, and other biological functions. Crit Rev Oncog 1994;3:27
   Google Scholar
• Miller SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994;266:F129-34
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Watanabe Y, Kasai S, et al. Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Transpl Int 2002;15:156-62
   PubMed Web of Science ®Google Scholar
• Takada S, Namiki M, Takahara S, et al. Serum HGF levels in acute renal rejection after living related renal transplantation. Transpl Int 1996;9:151-4
   PubMed Web of Science ®Google Scholar
• Mahmoud K, Opelz G, Pelzl S, et al. Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection. Transplantation 2007;83:1035-40
   PubMed Web of Science ®Google Scholar
• Fu YW, Wang WG, Zhou HL, Cai L. Presence of donor-and-recipient-derived DNA microchimerism in the cell-free blood samples of renal transplantation recipients associates with the acceptance of transplanted kidneys. Asian J Androl 2006;8:477-82
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Park J, Jacobson LM, et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004;66:1686-93
   PubMed Web of Science ®Google Scholar
• Hauser IA, Schaeffeler E, Gauer S, et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 2005;16:1501-11
   PubMed Web of Science ®Google Scholar
• Akcay A, Sezer S, Ozdemir FN, et al. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation 2004;78:892-8
   PubMed Web of Science ®Google Scholar
• Akcay A, Ozdemir FN, Atac FB, et al. Angiotensin-converting enzyme genotype is a predictive factor in the peak panel-reactive antibody response. Transplant Proc 2004;36:35-7
   PubMed Web of Science ®Google Scholar
• Barocci S, Ginevri F, Valente U, et al. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis. Transplantation 1999;67:534-8
   PubMed Web of Science ®Google Scholar
• Beige J, Scherer S, Weber A, et al. Angiotensin-converting enzyme genotype and renal allograft survival. J Am Soc Nephrol 1997;8:1319-23
   PubMed Web of Science ®Google Scholar
• Beige J, Offermann G, Distler A, Sharma AM. Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival. Nephrol Dial Transplant 1998;13:735-8
   PubMed Web of Science ®Google Scholar
• Abdi R, Tran TB, Zee R, et al. Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 2001;72:726-9
   PubMed Web of Science ®Google Scholar
• Sezer S, Uyar M, Akcay A, et al. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients. Transplant Proc 2005;37:776-8
   PubMed Web of Science ®Google Scholar
• Scolari MP, Cappuccilli ML, Lanci N, et al. Predictive factors in chronic allograft nephropathy. Transplant Proc 2005;37:2482-4
   PubMed Web of Science ®Google Scholar
• Chow KM, Szeto CC, Poon P, et al. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients. Ren Fail 2005;27:671-5
   PubMed Web of Science ®Google Scholar
• Kruger B, Schroppel B, Ashkan R, et al. A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002;13:2585-9
   PubMed Web of Science ®Google Scholar
• Poggio ED, Roddy M, Riley J, et al. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant 2005;24:1606-13
   PubMed Web of Science ®Google Scholar
• Najafian N, Salama AD, Fedoseyeva EV, et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002;13:252-9
   PubMed Web of Science ®Google Scholar
• Hricik DE, Rodriguez V, Riley J, et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003;3:878-84
   PubMed Web of Science ®Google Scholar
• Clarke W, Silverman BC, Zhang Z, et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003;237:660-4; discussion 664-5
   PubMed Web of Science ®Google Scholar
• Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004;15:219-27
   PubMed Web of Science ®Google Scholar
• Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005;5:729-38
   PubMed Web of Science ®Google Scholar
• Wishart DS. Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 2006;15:637-42
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Bollard ME, et al. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004;9:1-31
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-9
   PubMed Web of Science ®Google Scholar
• Serkova N, Fuller TF, Klawitter J, et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005;67:1142-51
   PubMed Web of Science ®Google Scholar
• Fuller TF, Serkova N, Niemann CU, Freise CE. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J Urol 2004;171:1296-300
   PubMed Web of Science ®Google Scholar
• Hauet T, Baumert H, Gibelin H, et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 2000;41:280-91
   PubMed Web of Science ®Google Scholar
• Domanski L, Safranow K, Jakubowska K, et al. Oxypurine and nucleoside concentrations in renal veins during reperfusion are predictors of early graft function. Scand J Urol Nephrol 2007;41:161-7
   PubMed Web of Science ®Google Scholar
• Annesley TM, Clayton LT. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin Chem 2005;51:872-7
   PubMed Web of Science ®Google Scholar
• Vollenbroeker B, Koch JH, Fobker M, et al. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters. Transplant Proc 2005;37:1741-4
   PubMed Web of Science ®Google Scholar
• Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003;349:125-38
   PubMed Web of Science ®Google Scholar
• Eikmans M, Roos Van Groningen MC, Sijpkens YW, et al. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value. J Am Soc Nephrol 2005;16:3771-86
   PubMed Web of Science ®Google Scholar
• Vargha R, Mueller T, Arbeiter K, et al. C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection. Pediatr Transplant 2006;10:449-53
   PubMed Web of Science ®Google Scholar
• Jianghua C, Wenqing X, Huiping W, et al. C4d as a significant predictor for humoral rejection in renal allografts. Clin Transplant 2005;19:785-91
   PubMed Web of Science ®Google Scholar
• Johnson TS, Abo Zenah H, Skill JN, et al. Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy? Transplantation 2004;77:1667-75
   PubMed Web of Science ®Google Scholar
• August C, Brockmann J, Vowinkel T, et al. Stress associated proteins metallothionein, HO-1 and HSP 70 in human zero-hour biopsies of transplanted kidneys. Virchows Arch 2006;449:192-9
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Miyagi M, Ishikawa Y, et al. Estimation of damaged tubular epithelium in renal allografts by determination of vimentin expression. Int J Urol 2004;11:954-62
   PubMed Web of Science ®Google Scholar
• Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006;21:856-63
   PubMed Web of Science ®Google Scholar
• Harris S, Coupes BM, Roberts SA, et al. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 2007;20:177-85
   PubMed Web of Science ®Google Scholar